Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 17, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • Covid antibodies

Tag: Covid antibodies

  • BiotechToday
  • World

Understanding the potential of the Coronavirus alpha variant

BioTech Today July 3, 2021July 3, 2021 3

Neha khan, Jamia Millia Islamia What is the alpha variant? The B.1.1.7 variant is known as the Alpha variant which was first found in India and had taken thousands of lives. This coronavirus variant is more infectious than other variants because it foils the innate immune system for a while till it replicates and finds […]

Read More
  • BiotechToday
  • India

INDIA’S CALL FOR PFIZER AGAINST COVID 19

bioxone December 8, 2020December 8, 2020 1

SHRESTHA DUTTA, AMITY UNIVERSITY KOLKATA The authorization for Pfizer’s vaccine candidate came in just 10 months since it initiated developing it, which is the fastest in the history of vaccines. Pfizer has become the main organization to seek emergency use endorsement of its immunization applicant in India after getting clearance in the UK and Bahrain. […]

Read More
  • BiotechToday
  • World

Pfizer— coming to rescue from next week.

bioxone December 3, 2020December 3, 2020

Shrestha Dutta, Amity University Kolkata England affirmed Pfizer COVID-19 antibody on Wednesday, hoping in front of the United States and Europe to turn into the West’s first nation to officially embrace a hit it said should reach the most susceptible individuals early next week. PM Boris Johnson promoted the medication authority’s endorsement as a worldwide […]

Read More
  • BiotechToday
  • World

Covid updates- Quantification of antibody through plasmonic substrates for SARS-CoV-2 Detection

bioxone October 31, 2020October 31, 2020 3

Sagnik  Nag, Amity University Kolkata The emergence of an exceedingly pathogenic human Coronavirus in the Middle East has sparked novel concern in human coronaviruses around the world. Standing today we know all the precautions that are to be followed during this pandemic situation. The general symptoms about the outbreak of the Covid -19, but the […]

Read More

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy